TKA PCR: In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA

Sponsor
The University of Tennessee, Knoxville (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04103502
Collaborator
MicroPort Orthopedics Inc. (Industry)
24
3
19
8
0.4

Study Details

Study Description

Brief Summary

In vivo knee kinematics will be assessed for 20 subjects that have been implanted with either a MicroPort Medial Pivot or DePuy Attune posterior cruciate retaining (PCR) total knee arthroplasty (TKA) by Dr. Russell Nevins of Nevada Orthopedic & Spine Center [this is the location from which participants will be recruited].

Condition or Disease Intervention/Treatment Phase
  • Device: MicroPort Medial Pivot TKA
  • Device: DePuy Attune PCR TKA

Detailed Description

There will be ten subjects with the MicroPort implant and ten with the DePuy Attune implant; however, we will increase enrollment to 24 subjects (12 in each group) to ensure that researchers acquire the necessary 20 usable datasets for analysis and also to account for any subjects that may drop out of the study. All TKAs should be judged clinically successful based on the surgeon's evaluation and each patient's Forgotten Knee Score. Each subject should have a well-functioning prosthesis, be at least six months post-operative, and should have good-to-excellent post-operative passive flexion.

Study Design

Study Type:
Observational
Anticipated Enrollment :
24 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune Posterior Cruciate Retainign Total Knee Arthroplasty
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
MicroPort Medial Pivot

Subjects will have been implanted with the MicroPort Medial Pivot TKA

Device: MicroPort Medial Pivot TKA
Subjects will have been implanted with the MicroPort Medial Pivot TKA

DePuy Attune

Subjects will have been implanted with the DePuy Attune PCR TKA

Device: DePuy Attune PCR TKA
Subjects will have been implanted with the DePuy Attune PCR TKA

Outcome Measures

Primary Outcome Measures

  1. Kinematics Translations during Deep Knee Bend Activity [at least 6 months post-operative]

    Anterior Posterior (AP) translations of lateralfemoral condyles during deep knee bend

  2. Kinematics during Deep Knee Bend Activity [at least 6 months post-operative]

    Maximum weight-bearing flexion during DKB Axial Rotation (AR) during DKB

  3. Kinematics Translations during step up activity [at least 6 months post-operative]

    Anterior Posterior (AP) translations of lateralfemoral condyles during step up activity

  4. Kinematics during step up activity [at least 6 months post-operative]

    Maximum weight-bearing flexion during DKB Axial Rotation (AR) during step up activity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects will have either a MicroPort Medial Pivot or DePuy Attune PCR TKA.

  • Subjects must be at least six months post-operative.

  • Participants must be judged clinically successful based on the surgeon's evaluation and their Forgotten Knee Score.

  • Participants must be able to perform the required activities - stepping up and a deep knee bend.

  • Subjects must be willing to sign the Informed Consent (IC) / HIPAA form to participate in the study

Exclusion Criteria:
  • Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study.

  • Subjects without one of the two types of knee implants under investigation.

  • Subjects who are unable to perform stepping up and deep knee bend.

  • Subjects who are unwilling to sign Informed Consent/ HIPAA documents.

  • Does not speak English.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nevada Orthopedic & Spine Center Las Vegas Nevada United States 89128
2 Platinum Training/MERIN Las Vegas Nevada United States 89130
3 The University of Tennessee Knoxville Tennessee United States 37934

Sponsors and Collaborators

  • The University of Tennessee, Knoxville
  • MicroPort Orthopedics Inc.

Investigators

  • Principal Investigator: Richard Komistek, Ph.D., The University of Tennessee

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Richard Komistek, Fred M. Roddy Professor of Biomedical Engineering, The University of Tennessee, Knoxville
ClinicalTrials.gov Identifier:
NCT04103502
Other Study ID Numbers:
  • WIRB20181868
First Posted:
Sep 25, 2019
Last Update Posted:
Oct 8, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 8, 2021